Can physical activity during work be designed so it promotes health among industrial workers?

Can productive work be redesigned to change physical behavior so it promotes health among industrial workers? A cluster randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN80969503

Enrollment

Registered

2021-09-10

Start date

2021-09-13

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal health among industrial workers Musculoskeletal Diseases

Interventions

This study will investigate a 12-week workplace intervention aiming to improve the musculoskeletal health of industrial workers by redesigning their productive work. More specifically, the interventio

1) training in using

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: =20 hours weekly work at one of the two participating production sites within the organization

Exclusion criteria

Exclusion criteria: 1. Workers only working night shifts 2. Workers known/expected to leave the company/department within the intervention period 3. Pregnancy

Design outcomes

Primary

Measure	Time frame
Low back pain intensity is measured with a numeric scale (NRS, 0-10) at baseline (following work for 5 days in week 1) and follow up (following work for 5 days at week 12)	—

Secondary

Measure	Time frame
1. Composition of physical behaviors (i.e., sitting, standing and active) during work measured with accelerometry at baseline (for 5 days in week 1) and follow up (for 5 days in week 12) 2. Accumulated time in long bouts of sitting and standing during work measured with accelerometry at baseline (for 5 days in week 1) and follow up (for 5 days in week 12) 3. Perceived physical exertion at work measured with a numeric scale (0-10) measured at baseline (following work for 5 days at week 1) and follow up (following work for 5 days at week 12) 4. Fatigue and energy levels measured with a numeric scale (0-10) measured at baseline (following work for 5 days at week 1) and follow up (following work for 5 days at week 12) 5. Self-rated productivity at work measured on a numeric scale (0-10) at baseline (week 1) and follow up (week 12) 6. Cost-effectiveness measured by incremental change in cost-effectiveness (ratio of incremental change in cost and change in low back pain intensity) and return on investment (indicated by the return-on-investment ratio) collected during the 12-week intervention 7. Dose delivered, dose received and fidelity measured with records of consultations delivered (conducted in weeks 1, 4 and 7), list of participants (collected at weeks 1, 4 and 7), and work schedules (collected at weeks 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 weeks)	—

Measure

Time frame

1. Composition of physical behaviors (i.e., sitting, standing and active) during work measured with accelerometry at baseline (for 5 days in week 1) and follow up (for 5 days in week 12) 2. Accumulated time in long bouts of sitting and standing during work measured with accelerometry at baseline (for 5 days in week 1) and follow up (for 5 days in week 12) 3. Perceived physical exertion at work measured with a numeric scale (0-10) measured at baseline (following work for 5 days at week 1) and follow up (following work for 5 days at week 12) 4. Fatigue and energy levels measured with a numeric scale (0-10) measured at baseline (following work for 5 days at week 1) and follow up (following work for 5 days at week 12) 5. Self-rated productivity at work measured on a numeric scale (0-10) at baseline (week 1) and follow up (week 12) 6. Cost-effectiveness measured by incremental change in cost-effectiveness (ratio of incremental change in cost and change in low back pain intensity) and return on investment (indicated by the return-on-investment ratio) collected during the 12-week intervention 7. Dose delivered, dose received and fidelity measured with records of consultations delivered (conducted in weeks 1, 4 and 7), list of participants (collected at weeks 1, 4 and 7), and work schedules (collected at weeks 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 weeks)

—

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026